Home Recent Articles ŌURA Secures $200 Mn in Series D Funding

ŌURA Secures $200 Mn in Series D Funding

0
ŌURA, the company behind Oura Ring, the world’s leading smart ring, announced the completion of a $200 million Series D funding round. Fidelity Management & Research Company and Dexcom, the global leader in glucose biosensing, participated in the round. The investment raises the company’s valuation to $5.2 billion.
ŌURA, the company behind Oura Ring, the world’s leading smart ring, announced the completion of a $200 million Series D funding round. Fidelity Management & Research Company and Dexcom, the global leader in glucose biosensing, participated in the round. The investment raises the company’s valuation to $5.2 billion.
ŌURA, the company behind Oura Ring, the world’s leading smart ring, announced the completion of a $200 million Series D funding round. Fidelity Management & Research Company and Dexcom, the global leader in glucose biosensing, participated in the round. The investment raises the company’s valuation to $5.2 billion.

ŌURA, the company behind Oura Ring, the world’s leading smart ring, announced the completion of a $200 million Series D funding round. Fidelity Management & Research Company and Dexcom, the global leader in glucose biosensing, participated in the round. The investment raises the company’s valuation to $5.2 billion.

Read also – Borealis Biosciences Secures $30 Mn Series A Funding

This financing reflects ŌURA’s momentum in building and leading the smart ring category and the shared belief among its partners and investors that substantial growth opportunities are ahead. This new capital will enable ŌURA to expand its product offerings, fuel further investment in product, science, and healthcare innovation, including AI, advance global expansion efforts, and explore additional acquisitions to accelerate growth.

Read also – Fervo Energy Secures Additional $255 Mn Funding to Meet Unprecedented Energy Demand

“As we continue to drive momentum and growth, we are bolstered by the additional support of these investors,” said Tom Hale, ŌURA chief executive officer. “We’ve made significant progress in advancing our mission to make health a daily practice and will use this funding to unlock new opportunities, with AI development at the center of our strategy. We know that ŌURA has the potential to change lives at scale, and we’re excited to continue leading the market in innovation while pursuing opportunities that extend beyond the ring.”

This funding milestone follows a period of marked growth for ŌURA. The company recently surpassed 2.5 million rings sold and has seen its member base and revenue more than double over the past year. This year, ŌURA expanded its retail presence globally with new retail partnerships such as Amazon and Target and grew its commercial business with expanded military partnerships, including the Naval Health Research Center (NHRC), the Air Force, and the Defense Innovation Unit. Further, ŌURA recently announced the acquisitions of Sparta Science and Veri, a first-of-its-kind partnership with Medicare Advantage provider Essence Healthcare, and a strategic metabolic-health partnership with Dexcom.

“Wearable tech is for anyone who wants to better understand the state of their health and live more optimally, for longer,” said Hale. “We’re committed to continuing our relentless pace of innovation and delivering exceptional value to Oura Members, and this new round of funding will enable us to do just that.”

About ŌURA

ŌURA delivers personalized health data, insights, and daily guidance with Oura Ring, the leading smart ring that helps you live healthier, longer. Guided by a mission of changing the healthcare paradigm from sick care to preventative health, ŌURA makes wellness and recovery a daily practice through sleep, activity, readiness, stress, resilience, women’s health, and heart health. Millions of Oura Members around the world use Oura Ring as a personalized health companion that meets them where they are.

Exit mobile version